作者:
Nicholson,S. [1]
;
Hall,E. [2]
;
Harland,S.J. [3]
;
Chester,J.D. [4]
;
Pickering,L. [5]
;
Barber,J. [6]
;
Elliott,T. [7]
;
Thomson,A. [8]
;
Burnett,S. [9]
;
Cruickshank,C. [10]
;
Carrington,B. ;
Waters,R. ;
Bahl,A.
作者单位:
Department of Clinical Oncology, Christie Hospital, Wilmslow Road, Manchester M20 4BX, United
[1]
Imperial College Healthcare NHS Trust, Department of Medical Oncology, Charing Cross Hospital
[2]
Velindre Cancer Centre, Velindre Hospital, Velindre Road, Whitchurch, Cardiff CF14 2TL, United
[3]
Department of Oncology, Royal Cornwall Hospital, London Road, Treliske, Truro TR1 3LJ, United
[4]
Leeds Institute of Molecular Medicine, University of Leeds and St. James's Institute of Oncology
[5]
Institute of Cancer Research, Clinical Trials and Statistics Unit, 123 Old Brompton Road, London
[6]
Bristol Haematology and Oncology Centre, Horfield Road, Bristol BS2 8ED, United Kingdom
[7]
Department of Oncology, University College London Hospitals NHSFT, 250 Euston Road, London NW1 2PG
[8]
Department of Oncology, St. Georges Hospital, Blackshaw Road, Tooting, London SW17 0QT, United
[9]
Department of Diagnostic Radiotherapy, Christie Hospital, Manchester, United Kingdom
[10]
发布时间
2014-01-21